Top Suppliers:I want be here
Related CAS#:
1467052-84-1 1406-14-0
6138-79-0 127228-87-9
1406-02-6 929-73-7
143851-98-3 1334385-87-3
56-99-5 75752-15-7
1247414-91-0 1346818-94-7
1345983-43-8 1346575-59-4
1249671-23-5 1250876-52-8
490024-14-1 1346517-82-5
1247179-62-9 869501-51-9

1467052-84-1

1467052-84-1 structure
1467052-84-1 structure
  • Name: Tazemetostat hydrochloride
  • Chemical Name: Tazemetostat hydrochloride
  • CAS Number: 1467052-84-1
  • Molecular Formula: C34H45ClN4O4
  • Molecular Weight: 609.20
  • Catalog: Signaling Pathways Epigenetics Histone Methyltransferase
  • Create Date: 2022-08-17 06:48:28
  • Modify Date: 2025-08-23 13:39:42
  • Tazemetostat (EPZ-6438) hydrochloride is a potent, selective and orally active EZH2 inhibitor with IC50 values of 11 and 16 nM for EZH2 peptide and nucleosome, respectively. Tazemetostat hydrochloride can be used for cancer research[1].
Name Tazemetostat hydrochloride
Description Tazemetostat (EPZ-6438) hydrochloride is a potent, selective and orally active EZH2 inhibitor with IC50 values of 11 and 16 nM for EZH2 peptide and nucleosome, respectively. Tazemetostat hydrochloride can be used for cancer research[1].
Related Catalog
In Vitro Tazemetostat (EPZ-6438; 0.49-7.6 μM, 11 days) hydrochloride inhibits multi wild-type and mutant lymphoma cell lines proliferation with IC50s of 0.49-7.6 μM[1]. Cell Cytotoxicity Assay[1] Cell Line: Wild-type and mutant lymphoma cell lines Concentration: 0.49-7.6 μM Incubation Time: 11 days Result: Inhibited DOHH-2 cell (EZH2 wild-type; IC50=1.7 μM), Farage cell (EZH2 wild-type; IC50=99 nM), OCI-LY19 cell (EZH2 wild-type; IC50=6.2 μM), Toledo cell (EZH2 wild-type; IC50=7.6 μM), KARPAS-422 (EZH2 Y646N; IC50=1.8 nM), Pfeiffer (EZH2 A682G; IC50=0.49 nM), RL cell line (EZH2 Y646N; IC50=5.8 μM), SU-DHL-10 (EZH2 Y646F; IC50=5.8 nM), SU-DHL-6 (EZH2 Y646N; IC50=4.7 nM), WSU-DLCL2 (EZH2 Y646F; IC50=8.6 nM) proliferation.
In Vivo Tazemetostat (EPZ-6438; 250-500 mg/kg; p.o.; twice daily; for 21-28 days) hydrochloride practically eliminates the fast-growing G401 tumors[1]. Animal Model: SCID mice bearing s.c. G401 xenografts[1] Dosage: 125 mg/kg, 250 mg/kg and 500 mg/kg Administration: Oral administration; twice daily; 28 days Result: Eliminated the fast-growing G401 tumors.
References

[1]. Knutson SK, et, al. Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferaseEZH2. Proc Natl Acad Sci U S A. 2013 May 7;110(19):7922-7.
Molecular Formula C34H45ClN4O4
Molecular Weight 609.20
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.

Chemsrc provides CAS#:1467052-84-1 MSDS, density, melting point, boiling point, structure, formula, molecular weight, synthetic route, etc.
title: CAS No. 1467052-84-1 | Chemsrc address: https://www.chemsrc.com/en/baike/1710544.html

Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer

Copyright © 2024 ChemSrc All Rights Reserved